Can You Die From a Trazodone Overdose?

Trazodone overdose can be fatal, but death from trazodone alone is genuinely rare. The published medical literature contains only a handful of confirmed deaths where trazodone was the sole substance involved, and most of those required massive doses well beyond what a typical prescription provides. The real danger spikes when trazodone is combined with other drugs or alcohol, which is also the pattern behind most overdose fatalities reported to poison control centers. That relative safety compared to older antidepressants is part of why trazodone remains so widely prescribed, but “relatively safe” is not “harmless,” and the ways trazodone can injure or kill a person are worth understanding clearly.

What Makes a Trazodone Overdose Dangerous

Trazodone works through several mechanisms at once. It blocks serotonin type 2 receptors, weakly inhibits serotonin reuptake, blocks histamine receptors, and blocks alpha-1-adrenergic receptors.¹ At normal doses these actions produce sedation and antidepressant effects. In overdose, they amplify into threats that hit the heart, the blood vessels, and the brain.

The cardiovascular system takes the heaviest hit. Trazodone blocks certain potassium channels in heart cells at concentrations that become clinically relevant during an overdose. This slows the electrical recovery of the heart between beats, prolonging what’s called the QT interval on an electrocardiogram. A prolonged QT interval can trigger dangerous irregular heart rhythms, including a specific type of arrhythmia that can degenerate into cardiac arrest.² Case reports have documented this happening even in young patients with no prior heart disease.³ Lab studies confirm that trazodone inhibits these cardiac potassium channels at concentrations that would be reached in an overdose scenario, in a pattern similar to other drugs that have been pulled from markets for exactly this risk.⁴

Blood pressure is the other major cardiovascular concern. Because trazodone blocks alpha-1 receptors in blood vessel walls, an overdose can cause severe, sustained low blood pressure. One published case involved a person who ingested roughly 2,500 mg and developed persistent hypotension requiring aggressive intravenous fluids, blood-pressure-raising medications, and intensive care admission.¹ When blood pressure stays dangerously low for too long, organs start to fail.

Neurological complications round out the picture. Overdose can produce severe sedation progressing to loss of consciousness, and seizures have been reported in multiple cases. One 55-year-old woman developed generalized seizures, cardiogenic shock, and respiratory arrest after an intentional overdose.⁵ In an especially unusual case, a 37-year-old woman who ingested about 6,450 mg developed dangerously low sodium levels, seizures, and fatal brain swelling. That case was the first documented death from a neurological rather than cardiac complication of pure trazodone overdose.⁶

Why Most Trazodone-Only Overdoses Are Survivable

Despite these serious complications, the overall track record of trazodone-only overdoses is one of survival. An early review covering four years of voluntary reports to the manufacturer found that out of 206 reported trazodone overdoses, no deaths occurred. For perspective, during the same reporting period, older-generation antidepressants produced far worse outcomes: over 2,200 reported overdoses with tricyclic antidepressants resulted in 16 deaths, and 125 overdoses with a different class of antidepressant produced 3 deaths.⁷ A separate five-year safety review concluded that no deaths had been reported to the manufacturer when trazodone was the only agent taken.⁸

The handful of fatal pure-trazodone cases that have been published all involved very large amounts. The fatal brain-swelling case mentioned above involved 6,450 mg, which is more than 16 times the maximum standard daily dose. Forensic toxicology data supports this pattern: fatalities are rarely attributed solely to trazodone when blood concentrations are below about 9 mg/L, while the normal upper therapeutic blood level is around 2 mg/L.⁹ In other words, blood levels generally need to be several times above the therapeutic range before trazodone alone becomes lethal. This wide gap between a therapeutic dose and a lethal dose is what gives trazodone its reputation as a relatively forgiving drug in overdose.

The Picture Changes When Other Substances Are Involved

The safety margin shrinks dramatically when trazodone is mixed with other substances. In the same four-year reporting dataset where zero single-drug trazodone deaths occurred, nine deaths were recorded in patients who had taken trazodone in combination with other drugs or alcohol.⁷ Forensic case reviews echo this finding: trazodone’s toxicity appears to be amplified by the presence of other drugs and by underlying health problems.⁹

This matters practically because trazodone is very often prescribed alongside other medications. A person taking trazodone for sleep might also be on a different antidepressant, a benzodiazepine for anxiety, or a pain medication. Alcohol is common among people with depression. In an overdose scenario, each additional substance can lower blood pressure further, deepen sedation, or add its own cardiac risks on top of trazodone’s. The combination doesn’t just add risks together; it can multiply them.

How It Compares to Other Antidepressants in Overdose

Trazodone was originally developed and promoted partly on the basis of being safer in overdose than the tricyclic antidepressants that dominated the market before selective serotonin reuptake inhibitors (SSRIs) arrived. Tricyclics are genuinely dangerous when taken in excess. They cause severe cardiac conduction abnormalities, seizures, and death at relatively modest multiples of the therapeutic dose. The safety review comparing trazodone to tricyclics over five years described the older drugs as “potentially lethal when taken in overdose” while characterizing trazodone as “relatively safe.”⁸

This comparison is real and clinically meaningful. A person determined to harm themselves with tricyclic antidepressants needs far fewer pills to reach a life-threatening dose than someone with trazodone. For clinicians prescribing to patients at risk of self-harm, that difference influences which medications they choose. Trazodone is not uniquely safe among modern antidepressants in this regard, as SSRIs also tend to have wide safety margins, but the contrast with tricyclics is stark enough that it shaped how trazodone found its niche in clinical practice.

Accidental Ingestion in Young Children

Because trazodone is so common in households (more on that below), accidental ingestion by small children is a real concern. A 16-year analysis of unintentional trazodone overdoses in children aged six and under, drawn from poison center data, examined 84 cases. The results were reassuring overall: about 62% of the children showed no symptoms at all, roughly 35% had only minor effects like vomiting or dizziness, and about 4% had moderate effects including unsteady movement and slurred speech. No major effects or deaths occurred.¹⁰

Moderate effects appeared at doses of roughly 7 mg per kilogram of body weight or higher. One concerning finding was a case of priapism in a two-year-old boy at that dose threshold. Children who had ingested smaller amounts, below about 6 mg per kilogram, did not develop anything worse than mild symptoms, even among those sent to the hospital for observation.¹⁰ All children recovered fully. Still, any accidental medication ingestion in a young child warrants a call to poison control, since the dose is often uncertain and toddlers can be unpredictable in how they metabolize drugs.

Why Trazodone Is Everywhere in Medicine Cabinets

Part of the reason trazodone overdose comes up as a question is sheer volume of use. Trazodone was originally approved as an antidepressant, but that is no longer how most of it gets prescribed. An analysis using nationally representative prescription data estimated that roughly 24 million trazodone prescriptions were filled in the United States in 2019, and at least 85% of those, about 20 million prescriptions, were for off-label uses, primarily insomnia.¹¹ Its sedating properties, low cost as a generic, and the perception that it is non-addictive have made it one of the most commonly prescribed sleep aids in the country.

That ubiquity means trazodone is sitting in a lot of bathroom cabinets, accessible to children, to people in crisis, and to individuals who might combine it with alcohol without thinking much about it. It also means the drug is frequently prescribed to elderly patients, who tend to be on multiple medications and who are more vulnerable to the blood-pressure-lowering effects that become dangerous in overdose. The drug’s widespread off-label use for sleep also means that many people taking it may not fully appreciate that they are taking an antidepressant with real pharmacological potency, not a simple sleeping pill.

Metabolism and Individual Variation

How your body processes trazodone can influence how toxic a given dose turns out to be. The liver converts trazodone into an active metabolite called mCPP, which affects serotonin receptors and produces its own set of neurological effects.¹² The primary liver enzyme responsible for this conversion is CYP3A4, one of the most active drug-metabolizing enzymes in the body.¹³

Individual differences in how well these enzymes function can change the drug’s effects. Research has found that people with reduced activity of a different liver enzyme, CYP2D6, may accumulate more of the mCPP metabolite and experience more side effects from trazodone as a result.¹⁴ Other medications that inhibit CYP3A4, such as certain antifungals and antibiotics, can also slow trazodone’s breakdown and effectively increase the amount circulating in the blood. In an overdose situation, these metabolic differences could theoretically push someone into a more dangerous range at a lower total dose, though this has not been studied directly in overdose patients.

Forensic Toxicology and Establishing Cause of Death

When trazodone shows up in a postmortem investigation, medical examiners face a nuanced task. One forensic study found that trazodone peripheral blood concentrations up to about 1.0 mg/L could generally be considered non-toxic, while liver concentrations up to about 2.2 mg/kg fell in the same safe range.¹⁵ The same study found that trazodone does not appear to undergo significant redistribution after death, meaning the blood levels measured at autopsy probably reflect actual levels at the time of death rather than an artifact of the drug leaking from tissues. This makes interpretation more straightforward than for some other drugs.

In a separate forensic review, trazodone was considered to have played a primary role in the death of three subjects, all of whom had blood concentrations above 9 mg/L, roughly four and a half times the upper therapeutic level.⁹ Even among these cases, the authors noted that other drugs and underlying health conditions could influence toxicity. The forensic picture confirms the clinical one: trazodone alone is hard to die from unless the amount taken is extreme.

Priapism as a Unique Risk

Trazodone carries a distinctive side effect that rarely comes up with other antidepressants: priapism, a sustained, painful erection that requires emergency medical treatment. This is not an overdose-specific risk; it can occur at therapeutic doses. The mechanism is thought to involve trazodone’s alpha-adrenergic blocking properties acting locally on blood vessels in penile tissue, preventing the normal outflow of blood.¹⁶ Priapism was even documented in the pediatric overdose data, occurring in a two-year-old boy after accidental ingestion.¹⁰

While priapism is not fatal, untreated cases can lead to permanent tissue damage. It is one of the reasons trazodone prescriptions come with specific warnings, and one of the complications that makes any overdose, even a non-lethal one, potentially consequential.

Emergency Treatment in Severe Cases

Treatment of trazodone overdose is primarily supportive. There is no specific antidote. Hospital management focuses on maintaining blood pressure with intravenous fluids and vasopressor medications, managing seizures if they occur, monitoring heart rhythm closely, and providing breathing support if consciousness is deeply impaired. Most patients who receive timely medical care survive.

For extreme cases where the heart stops, an emerging approach involves lipid emulsion therapy, essentially infusing a fat-based solution intravenously. This technique was originally developed for overdoses of local anesthetics but has been tried with other fat-soluble drugs. At least one published case describes successful use of lipid emulsion therapy in a patient who went into cardiac arrest after a trazodone overdose.¹⁷ The evidence base is limited to individual case reports, so this is not standard first-line treatment, but it represents a potential rescue option when conventional resuscitation fails. The fact that clinicians are exploring novel treatments for severe trazodone poisoning reflects a recognition that while deaths are rare, the cases that do become life-threatening can be very difficult to manage once they progress to cardiac arrest or refractory shock.

1
PubMed Central. Management of Trazodone Overdose with Severe Hypotension
2
PubMed Central. Torsades de Pointe Associated with Trazodone Consumption
3
PubMed. QT Prolongation and delayed atrioventricular conduction caused by acute ingestion of trazodone
4
PubMed. Effect of trazodone on hERG channel current and QT-interval
5
PubMed Central. Arrhythmias in Severe Trazodone Overdose
6
PubMed. Fatal Cerebral Edema, Seizures, and Hyponatremia After Trazodone Overdose
7
PubMed. Trazodone overdose: four years of experience from voluntary reports
8
PubMed. The greater safety of trazodone over tricyclic antidepressant agents: 5-year experience in the United States
9
PubMed. Postmortem forensic toxicology of trazodone
10
PubMed. Unintentional trazodone overdoses in children ≤6 years of age: data from poison center over a period of 16 years
11
PubMed Central. Off-label policy through the lens of trazodone usage and spending in the United States
12
Drug Metabolism and Disposition. Trazodone Is Metabolized to m-Chlorophenylpiperazine by CYP3A4 from Human Sources
13
PubMed. Metabolism of m-CPP, trazodone, nefazodone, and etoperidone: clinical and forensic aspects
14
PubMed Central. CYP2D6 Phenotype as a Predictor of Adverse Drug Reactions in Patients Treated With Trazodone: An Explorative Pharmacogenetic Study
15
PubMed. Postmortem distribution of trazodone concentrations
16
PubMed. Priapism induced by chlorpromazine and trazodone: mechanism of action
17
PubMed Central. A Case of Trazodone Overdose Successfully Rescued With Lipid Emulsion Therapy